KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Cardlytics (CDLX) Return on Sales (2017 - 2026)

Cardlytics filings provide 10 years of Return on Sales readings, the most recent being 0.0% for Q1 2026.

  • Quarterly Return on Sales changed 0.0% to 0.0% in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 0.0% through Mar 2026, changed 0.0% year-over-year, with the annual reading at 0.0% for FY2025, 0.0% changed from the prior year.
  • Return on Sales hit 0.0% in Q1 2026 for Cardlytics, up from 0.0% in the prior quarter.
  • Across five years, Return on Sales topped out at 0.0% in Q1 2022 and bottomed at 0.05% in Q4 2022.
  • Average Return on Sales over 5 years is 0.01%, with a median of 0.0% recorded in 2024.
  • The largest annual shift saw Return on Sales dropped -4bps in 2022 before it rose 3bps in 2023.
  • Cardlytics' Return on Sales stood at 0.05% in 2022, then skyrocketed by 75bps to 0.01% in 2023, then surged by 81bps to 0.0% in 2024, then soared by 30bps to 0.0% in 2025, then skyrocketed by 285bps to 0.0% in 2026.
  • Per Business Quant, the three most recent readings for CDLX's Return on Sales are 0.0% (Q1 2026), 0.0% (Q4 2025), and 0.01% (Q3 2025).